To evaluate the new therapies in acute or chronic renal failure, to improve
teaching and to develop basic research, will be the goals of the Nephrolog
y Units in the future, in the hospitals and in the universities as well.
The treatment of acute renal failure : 1) Evaluate new methods of dialysis
that should be less aggressive than hemodialysis, such as hemodiafiltration
, in order to decrease the hemodynamic risks of an elder population. 2) Imp
rove teaching : education of students and of physicians at the University m
ust be more effective to allow a better diagnosis of acute renal failure an
d therefore its prevention, and a rapid histological examination of renal t
issue that constitutes the basis of etiopathogenic treatment of glomerular
and/or vascular nephropathies.
The treatment of chronic renal failure : 1) Improve and develop the present
therapy. automated peritoneal dialysis at home should be developed. 2) The
evaluation of new techniques of hemodialysis in the patient can only be un
dertaken at the University Hospitals. New experimental procedures can endow
the artificial kidney, with most of the metabolic functions of normal kidn
ey. This method has not been tested yet in men. 3) The xenografts are very
interesting approaches because of the lack of organs, however there ave maj
or obstacles including insufficient knowledge of the mechanisms of hyperacu
te graft rejection, of the possibility of transmission of anthropozoonoses
front animals to humans, and of gene mutation of virus that usually are not
pathogenic in man; finally studies on the adaptation of the xenograft, whi
ch possess different biological parameters, to the human milieu, should be
considered. 4) Cell therapy or gene therapy are currently under investigati
on. The major difficulties are to assess that the vector used to transfer t
he gene is absolutely harmless to man and to restrict the gene delivery to
the cells of interest.
The molecular genetics determinants should be essential to prevent kidney d
iseases because they would help in defining the individual susceptibilities
to develop nephropathies.